Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
PRINCIPAL FINANCIAL GROUP INC
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 620,489 | 589,229 | 15,704,564,000 | 14,697,680,000 | $25,309.98 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 31,260 | 12,657 | 1,006,884,000 | 1,006,382,000 | $32,209.98 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 18,603 | -290 | 502,000 | 241,000 | $26.98 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 18,893 | 6,043 | 261,000 | 10,000 | $13.81 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 12,850 | 913 | 251,000 | 56,000 | $19.53 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 11,937 | -691,506 | 195,000 | -19,403,000 | $16.34 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 703,443 | 24,812 | 19,598,000 | -517,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 678,631 | 130,338 | 20,115,000 | 4,791,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 548,293 | 114,515 | 15,324,000 | 3,030,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 433,778 | -134,067 | 12,294,000 | -1,982,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 567,845 | 3,087 | 14,276,000 | 484,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 564,758 | 161,601 | 13,792,000 | 7,825,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 403,157 | -13,409 | 5,967,000 | -794,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 416,566 | 93,213 | 6,761,000 | 2,557,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 323,353 | 99,788 | 4,204,000 | 1,304,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 223,565 | 109,297 | 2,900,000 | 1,099,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 114,268 | 167 | 1,801,000 | -496,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 114,101 | -14,043 | 2,297,000 | -887,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 128,144 | 2,236 | 3,184,000 | -272,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 125,908 | -112 | 3,456,000 | -425,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 126,020 | -160 | 3,881,000 | -630,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 126,180 | 48,121 | 4,511,000 | 2,360,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 78,059 | -3,375 | 2,151,000 | 1,000 | $27.56 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 81,434 | 221 | 2,150,000 | 469,000 | $26.40 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 81,213 | 861 | 1,681,000 | 378,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 80,352 | -1,396 | 1,303,000 | -1,490,000 | $16.22 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 79,967 | -1,305 | 1,087,000 | -332,000 | $13.59 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 81,272 | -476 | 1,419,000 | -1,374,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 81,748 | 11,108 | 2,793,000 | 1,329,000 | $34.17 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 78,267 | 7,627 | 2,329,000 | 865,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 76,765 | 6,125 | 2,455,000 | 991,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 70,640 | 70,640 | 1,463,000 | 1,463,000 | $20.71 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 72,438 | 72,438 | 1,227,000 | 1,227,000 | $16.94 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 72,616 | 72,616 | 1,404,000 | 1,404,000 | $19.33 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 67,035 | 67,035 | 2,279,000 | 2,279,000 | $34.00 |
| << Prev Next >> |
|